PharmaPrint Granted U.S. Patent

PharmaPrint Granted U.S. Patent

NEWPORT BEACH,Calif.--PharmaPrint Inc. has been issued patents in two countries for its PharmaPrint Process for producing high quality St. John's wort preparations. The U.S. Patent and Trademark Office issued patent #6,113,907, which covers the process, and the Australian Patent Office issued patent #716,155, which provides patent protection for the PharmaPrint Process in Australia. This patented technology precisely identifies and consistently replicates active ingredients from St. John'swort, according to the company. For more information, visit www.pharmaprint.com.